P3 Health Partners Inc. (PIII)
NASDAQ: PIII · Real-Time Price · USD
0.197
+0.009 (4.72%)
At close: Dec 20, 2024, 4:00 PM
0.209
+0.012 (6.13%)
After-hours: Dec 20, 2024, 7:57 PM EST

P3 Health Partners Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Revenue
1,4771,2661,049637.36491.06145.48
Revenue Growth (YoY)
25.38%20.67%64.66%29.79%237.54%-
Cost of Revenue
1,5171,2351,057659.34484.5141.03
Gross Profit
-40.231.64-7.75-21.986.564.45
Selling, General & Admin
113.45125.6162.38119.4154.8937.23
Other Operating Expenses
12.43-12.71-11.4637.84-20.546.36
Operating Expenses
212.42199.57238.21165.9735.1543.99
Operating Income
-252.62-167.93-245.96-187.95-28.59-39.54
Interest Expense
-19.39-15.99-11.4-10.68-2.53-2.53
Other Non Operating Income (Expenses)
16.670.1812.62-5.72-0.290.1
EBT Excluding Unusual Items
-255.34-183.73-244.74-204.34-31.41-41.97
Impairment of Goodwill
---1,315---
Pretax Income
-249.14-183.73-1,560-204.34-31.41-41.97
Income Tax Expense
1.22.71.86---
Earnings From Continuing Operations
-250.34-186.43-1,562-204.34-31.41-41.97
Minority Interest in Earnings
147.64128.651,29147.86--
Net Income
-102.69-57.77-270.13-156.48-31.41-41.97
Preferred Dividends & Other Adjustments
----146.4--
Net Income to Common
-102.69-57.77-270.13-10.08-31.41-41.97
Shares Outstanding (Basic)
1339542426648
Shares Outstanding (Diluted)
13329542426648
Shares Change (YoY)
74.54%608.51%--36.84%38.34%-
EPS (Basic)
-0.77-0.61-6.50-0.24-0.48-0.88
EPS (Diluted)
-1.20-0.63-6.50-0.24-0.48-0.88
Free Cash Flow
-68.56-77.86-128.25-69.88-27.52-29.74
Free Cash Flow Per Share
-0.51-0.26-3.08-1.68-0.42-0.62
Gross Margin
-2.72%2.50%-0.74%-3.45%1.34%3.06%
Operating Margin
-17.11%-13.26%-23.44%-29.49%-5.82%-27.18%
Profit Margin
-6.95%-4.56%-25.74%-1.58%-6.40%-28.85%
Free Cash Flow Margin
-4.64%-6.15%-12.22%-10.96%-5.60%-20.44%
EBITDA
-166.08-81.26-158.67-179.22-27.79-39.14
EBITDA Margin
-11.25%-6.42%-15.12%-28.12%-5.66%-26.90%
D&A For EBITDA
86.5486.6887.298.720.80.4
EBIT
-252.62-167.93-245.96-187.95-28.59-39.54
EBIT Margin
-17.11%-13.26%-23.44%-29.49%-5.82%-27.18%
Revenue as Reported
1,4771,2661,049637.36491.06145.48
Advertising Expenses
-3.24.52.1--
Source: S&P Capital IQ. Standard template. Financial Sources.